Serdexmethylphenidate/Dexmethylphenidate – A Promising Treatment Option for Childhood Attention Deficit Hyperactivity Disorder (ADHD)

Presenter Information

N Troy ToFollow
H Stephen LeeFollow

Description

To review the phase 2 and phase 3 clinical trials of Serdexmethylphenidate and dexmethylphenidate (SDX/d-MPH) in the treatment of Attention Deficit/Hyperactivity disorder (ADHD) in children.

Disciplines

Clinical Trials | Mental Disorders | Psychiatry

Recommended Citation

To, N Troy and Lee, H Stephen, "Serdexmethylphenidate/Dexmethylphenidate – A Promising Treatment Option for Childhood Attention Deficit Hyperactivity Disorder (ADHD)" (2023). Annual Research Symposium. 29.
https://ecommons.roseman.edu/researchsymposium/2023/postergroup5/29